Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance.

Linlin ShiJianyong ShengGuozhong ChenPeng ZhuChangping ShiBei LiChaiwoo ParkJingyi WangBixiang ZhangZhi LiuXiangliang Yang

Published in: Journal for immunotherapy of cancer (2021)

These findings propose that IL-2 combined with AKK is a novel therapeutic strategy with prospecting application for cancer treatment in clinical practice.

Keyphrases

immune response
clinical practice
dendritic cells
inflammatory response